Thorgerdur Palsdottir

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: EUROPEAN UROLOGY FOCUS. 2023;9(3):455-462
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort
Palsdottir T; Gronberg H; Hilmisson A; Eklund M; Nordstrom T; Vigneswaran HT
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:69-75
Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
Andersson J; Palsdottir T; Lantz A; Aly M; Gronberg H; Egevad L; Eklund M; Nordstrom T
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;41:1-7
External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort
Engel JC; Palsdottir T; Ankerst D; Remmers S; Mortezavi A; Chellappa V; Egevad L; Gronberg H; Eklund M; Nordstrom T
Article: JAMA ONCOLOGY. 2022;8(7):1019-1026
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
Bjornebo L; Nordstrom T; Discacciati A; Palsdottir T; Aly M; Gronberg H; Eklund M; Lantz A
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;38:32-39
A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines: Results from a Prospective Population-based Screening Study
Walden M; Aldrimer M; Lagerlof JH; Eklund M; Gronberg H; Nordstrom T; Palsdottir T
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2021;24(2):457-464
Biomarker discrimination and calibration with MRI-targeted biopsies: an analysis with the Stockholm3 test
Vigneswaran HT; Palsdottir T; Olsson H; Haug ES; Picker W; Loffeler S; Gronberg H; Eklund M; Nordstrom T
Article: EUROPEAN UROLOGY FOCUS. 2021;7(3):546-553
Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators
Mortezavi A; Palsdottir T; Eklund M; Chellappa V; Murugan SK; Saba K; Ankerst DP; Haug ES; Nordstrom T; Tilki D
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2021;24:11-16
Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms
Nordstrom T; Engel JC; Bergman M; Egevad L; Aly M; Eklund M; Palsdottir T; Gronberg H
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(1):1-6
Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml
Engel JC; Palsdottir T; Aly M; Egevad L; Gronberg H; Eklund M; Nordstrom T
Article: EUROPEAN UROLOGY ONCOLOGY. 2019;2(5):490-496
A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging
Palsdottir T; Nordstrom T; Aly M; Jaderling F; Clements M; Gronberg H; Eklund M
Article: BMJ OPEN. 2019;9(3):e027958
The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study
Palsdottir T; Nordstrom T; Karlsson A; Gronberg H; Clements M; Eklund M
Article: PLOS ONE. 2019;14(6):e0218280
Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study
Palsdottir T; Nordstrom T; Aly M; Lindberg J; Clements M; Egevad L; Gronberg H; Eklund M
Article: JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION : JAMIA. 2017;24(5):950-957
E-Science technologies in a workflow for personalized medicine using cancer screening as a case study
Spjuth O; Karlsson A; Clements M; Humphreys K; Ivansson E; Dowling J; Eklund M; Jauhiainen A; Czene K; Gronberg H; Sparen P; Wiklund F; Cheddad A; Palsdottir P; Rantalainen M; Abrahamsson L; Laure E; Litton J-E; Palmgren J

Alla övriga publikationer

Letter: HAEMATOLOGICA. 2022;107(3):740-743
Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017
Albertsson-Lindblad A; Palsdottir T; Smedby KE; Weibull CE; Glimelius I; Jerkeman M
Thesis / dissertation: 2019
Risk prediction in prostate cancer diagnostics : current challenges and improvements
Pálsdóttir, Þorgerður

Anställningar

Anknuten till Forskning, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2024-2027

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2019

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI